Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-Seq - Archive ouverte HAL Access content directly
Journal Articles Cell Host & Microbe Year : 2021

Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-Seq

(1) , (2) , (1) , (2) , (1)
1
2

Abstract

Streptococcus pneumoniae is an opportunistic human pathogen that causes invasive diseases, including pneumonia, with greater health risks upon influenza A virus (IAV) co-infection. To facilitate pathogenesis studies in vivo, we developed an inducible CRISPR interference system that enables genome-wide fitness testing in one sequencing step (CRISPRi-seq). We applied CRISPRi-seq to assess bottlenecks and identify pneumococcal genes important in a murine pneumonia model. A critical bottleneck occurs at 48 h with few bacteria causing systemic infection. This bottleneck is not present during IAV superinfection, facilitating identification of pneumococcal pathogenesis-related genes. Top in vivo essential genes included purA, encoding adenylsuccinate synthetase, and the cps operon required for capsule production. Surprisingly, CRISPRi-seq indicated no fitness-related role for pneumolysin during superinfection. Interestingly, although metK (encoding S-adenosylmethionine synthetase) was essential in vitro, it was dispensable in vivo. This highlights advantages of CRISPRi-seq over transposon-based genetic screens, as all genes, including essential genes, can be tested for pathogenesis potential.
Fichier principal
Vignette du fichier
2020.04.22.055319.full.pdf (1.86 Mo) Télécharger le fichier

Dates and versions

inserm-03299441 , version 1 (26-07-2021)

Identifiers

Cite

Xue Liu, Jacqueline Kimmey, Vincent de Bakker, Victor Nizet, Jan-Willem Veening. Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-Seq. Cell Host & Microbe, 2021, 29 (1), pp.107-120.e6. ⟨10.1016/j.chom.2020.10.001⟩. ⟨inserm-03299441⟩

Collections

INSERM
16 View
33 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More